BETOPTIC S Rx
Generic Name and Formulations:
Betaxolol HCl 0.25%; oph. susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for BETOPTIC S:
Open-angle glaucoma. Ocular hypertension.
Remove contact lenses before use; may reinsert 15mins after instillation. 1–2 drops twice daily.
Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure.
History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. COPD. Asthma. Pulmonary impairment. Measure intraocular pressure during 1st month of treatment. Diabetes (esp. labile). Vascular insufficiency; consider alternative therapy if reduced cerebral blood flow or Raynaud's phenomenon develop. History of atopy or anaphylaxis. May mask hypoglycemia and hyperthyroidism. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers.
May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics. Additive hypotension and/or marked bradycardia with concomitant calcium antagonists, antiarrhythmics, digitalis.
Transient discomfort, tearing. Rarely: decreased corneal sensitivity, erythema, itch, corneal punctate staining, keratitis, anisocoria, photophobia, depression, headache, bradycardia, dyspnea, hives.
Susp—2.5mL, 5mL, 10mL, 15mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Cognitive Impairment May Predict Persistent Psychosis in Ketamine Users
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders